Pericardiocentesis with cisplatin for malignant pericardial effusion and tamponade

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

328

HTML

2380

Tables (1-3)

163

Sum=2871

Feb 14, 2010 (publication date) through Jul 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Feb 14, 2010; 16(6): 740-744
Published online Feb 14, 2010. doi: 10.3748/wjg.v16.i6.740

Table 1 Characteristics of the patients

Patient No.	Age	Sex	Stage of esophageal cancer	Former treatment	Symptoms
1	68	M	T2, N1, M0: Stage IIB	Esophagectomy + chemotherapy	Dyspnea, tachycardia
2	69	M	T3, N1, M0: Stage III	Esophagectomy + chemotherapy	Dyspnea, tachycardia
3	64	M	T2, N1, M0: Stage III	Esophagectomy + chemotherapy	Dyspnea
4	70	M	T3, N1, M1a: Stage IVA	Esophagectomy + chemotherapy	Dyspnea, tachycardia
5	71	M	T2, N1, M1a: Stage IVA	Chemoradiotherapy	Dyspnea, tachycardia
6	65	M	T2, N1, M0: Stage IIB	Esophagectomy + chemotherapy	Dyspnea, tachycardia
7	62	M	T2, N1, M1a: Stage IVA	Chemoradiotherapy	Dyspnea

Citation: Oida T, Mimatsu K, Kano H, Kawasaki A, Kuboi Y, Fukino N, Amano S. Pericardiocentesis with cisplatin for malignant pericardial effusion and tamponade. World J Gastroenterol 2010; 16(6): 740-744
URL: https://www.wjgnet.com/1007-9327/full/v16/i6/740.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i6.740